CD44 Targeting of Cisplatin-Loaded Hyaluronic Acid-Modified Mesoporous Silica Nanoparticles for Lung Adenocarcinoma: Synthesis, Characterization, In Vitro and In Vivo Evaluation

<b>Background/Objectives:</b> Cisplatin (CDDP) is widely used in the treatment of non-small cell lung cancer (NSCLC); however, its clinical efficacy is limited by severe systemic toxicity. Hyaluronic acid (HA) modification enables the targeting of CD44-overexpressing cancer cells, enhances biocompat...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Cem Güler, S. Sacide Gelen, Ebru Şancı, Aylin Buhur, H. Ece Tıkır, Ayşe Nalbantsoy, Adem Güner, E. İlker Medine, Altuğ Yavaşoğlu, Dilek Odacı, N. Ülkü Karabay Yavaşoğlu
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2026-01-01
סדרה:	Pharmaceutics
נושאים:	cisplatin mesoporous silica nanoparticles hyaluronic acid CD44 drug delivery system active targeting
גישה מקוונת:	https://www.mdpi.com/1999-4923/18/2/171
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!